No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Lenalidomide shows improvement in progression-free survival over bortezomib maintenance following autologous stem cell transplantation for multiple myeloma

byKathleen Lau

January 28, 2021

in StudyGraphics

RELATED REPORTS

GPT-4 performing with superior scores on medical oncology examination questions

Addition of pembrolizumab to chemotherapy improves early-stage triple-negative breast cancer survival

Neoadjuvant ipilimumab plus nivolumab improves event-free survival in stage III melanoma

#VisualAbstract: Prognosis for advanced melanoma has improved between 2013 to 2017 for patients in the Netherlands

RelatedReports

Natural language processing may automate data extraction from radiologic reports

Oncology

GPT-4 performing with superior scores on medical oncology examination questions

December 17, 2024

Preoperative bilateral breast imaging may reduce contralateral cancer recurrence

Oncology

Addition of pembrolizumab to chemotherapy improves early-stage triple-negative breast cancer survival

December 16, 2024

Increased risk of subsequent melanoma after first melanoma diagnosis

Dermatology

Neoadjuvant ipilimumab plus nivolumab improves event-free survival in stage III melanoma

December 12, 2024

USPSTF recommends chemoprevention for women at high risk for breast cancer

Oncology

Inavolisib lengthens progression-free survival time in HER2-negative advanced breast cancer

December 11, 2024

Rilonacept may lower pericarditis recurrence in patients with relapsing pericarditis

Machine learning-based PRAISE score may aid in the prediction of adverse events following an acute coronary syndrome

Tamsulosin therapy associated with significant reduction of symptoms of overactive bladder

Insurance status linked to transfer decisions in trauma cases

Laryngeal mask airway may not be superior for neonate resuscitation

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result